-
mental disorders or enhancement",
published 16
December 2021, ****igned to
Tactogen Inc. WO 2023/107653,
Baggott MJ,
Lofthus SJ, De
Leona XM,
Singh A, Hudgins...
-
norepinephrine at a
concentration of 10 μM. BK-NM-AMT was
patented by
Tactogen in
October 2024.
Several 5-halogenated
derivatives of BK-NM-AMT have also...
-
benzodioxole ring
system replaced by benzofuran. The drug was
patented by
Tactogen in 2022. 6-APB 5-MAPB WO 2022/032147,
Baggott M, "2-Aminoindane compounds...
- 2022/010937,
Baggott M, "Advantageous
benzothiophene compositions for
mental disorders or enhancement.",
published 13
January 2022, ****igned to
Tactogen Inc. ...
-
concentration of 10 μM. BK-NM-AMT has been
described in a
patent ****igned to
Tactogen and
published in
October 2024. 5-Halogenated
derivatives of this drug,...
